Industries > Pharma > Global Smoking Cessation Drugs Market Forecast 2017-2027

Global Smoking Cessation Drugs Market Forecast 2017-2027

NRT, Non-nicotine Pharmacotherapy, Prescription Drugs, OTC Drugs

PUBLISHED: 31 October 2017
PAGES: 280
PRODUCT CODE: PHA0254

Clear
WOOCS 2.2.1
SKU: PHA0254 Categories: , ,

The global smoking cessation drugs market is expected to grow at a CAGR of 14.9% in the first half of the forecast period. In 2016, the non-nicotine pharmacotherapy submarket held 56.2% of the global smoking cessation drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 280-page report you will receive 175 tables and 150 figures– all unavailable elsewhere.

The 280-page report provides clear detailed insight into the global smoking cessation drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Smoking Cessation Drugs market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the global smoking cessation drugs market by type of therapy:
– NRT
– Non-Nicotine Pharmacotherapy

• This report also breaks down the revenue forecast for the global smoking cessation drugs market by prescription vs OTC:
– Prescription drugs
– OTC

• This report provides individual revenue forecasts to 2027 for these regions:
– North America
– Europe
– Asia-Pacific
– RoW

Each region is further segmented by type of therapy.

Global Smoking Cessation Drugs Market Forecast 2017-2027

• This report provides the following qualitative analysis:
– Epidemiology by geography, available treatment options, along with humanistic and economic burden
– A SWOT Analysis
– Pipeline molecules which are under development for the treatment of smoking cessation and detailed analysis on promising drug candidates
– Pricing and reimbursement overview of the smoking cessation drugs market.
– Leading companies that are the major players in the global smoking cessation drugs industry, including Pfizer, GlaxoSmithKline and Johnson & Johnson.

Visiongain’s study is intended for anyone requiring commercial analyses for the global smoking cessation drugs market. You find data, trends and predictions.

Buy our report today Global Smoking Cessation Drugs Market Forecast 2017-2027: NRT, Non-nicotine Pharmacotherapy, Prescription Drugs, OTC Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Smoking Cessation Drugs Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Smoking Cessation Drugs Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Visiongain Publishes Vaccine Sales Market Report 2022-2032

Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers.

30 March 2022

READ

Categories